Mouth cancer
A Study Comparing Side Effects and Quality of Life in Short vs Long Course Chemoradiation for Unresectable Oral Cancers
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine and radiation
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 24 Jun 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
ACTREC, Tata Memorial CentreNavi MumbaiDirections ↗
Registry summary (technical)
A Phase III Randomized Controlled Trial Evaluating Toxicity and Quality of Life between a Short Course of Hypofractionated versus Conventionally fractionated Chemoradiation for Locally Advanced Unresectable Oral Cancers - SHyne
Sponsor: Tata Memorial Centre
CTRI/2024/12/077881 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 24 Jun 2025 · read by us 5 Nov 2026